Skip to the page

Data / Form D filings / Eletala Enterprises Inc

Eletala Enterprises Inc: Form D filing

Eletala Enterprises Inc, a pharmaceuticals company in Wilmington, DE, filed a Form D with the SEC in 2026. The latest, on January 22, 2026, reports $100,000 sold of a $10 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
251 LITTLE FALLS DRIVE, Wilmington, DE, 19808
Phone
(833) 287-3632
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2106811

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 22, 2026New notice$10,000,000$100,000$9,900,0001Jan 11, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Richard Eugene FryeExecutive Officer, Director
Sri VenkateshExecutive Officer, Director
John N GaitanisExecutive Officer, Director

Every Form D from the week of Jan 19, 2026 · All recent filings in Delaware · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Eletala Enterprises Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.